Are you over 18 and want to see adult content?
More Annotations
A complete backup of littlecowpokes.net
Are you over 18 and want to see adult content?
A complete backup of sustainabilityconsortium.org
Are you over 18 and want to see adult content?
A complete backup of thehundredsclothing.com
Are you over 18 and want to see adult content?
Favourite Annotations
A complete backup of wormsandgermsblog.com
Are you over 18 and want to see adult content?
A complete backup of flashcardsecrets.com
Are you over 18 and want to see adult content?
A complete backup of settgosecapbio.cf
Are you over 18 and want to see adult content?
A complete backup of scr888slot.online
Are you over 18 and want to see adult content?
A complete backup of unbeatablesale.com
Are you over 18 and want to see adult content?
A complete backup of greenlifestylemag.com.au
Are you over 18 and want to see adult content?
Text
grants.
THIRD ANNUAL ALCON RETINA FELLOWS INSTITUTE GOES VIRTUAL Alcon, the global leader in eye care dedicated to helping people see brilliantly, will host the third annual Alcon Retina Fellows Institute – a unique educational experience which gathers 40 first-year Retina fellows for surgical training and mentorship from many leading ophthalmologists in the field across the United States. The Institute is convening virtually this year from November 19-21 ALCON ANNOUNCES LAUNCH OF ACRYSOF IQ VIVITY, THE FIRST AND Vivity is a first-of-its-kind, non-diffractive extended depth of focus IOL with Alcon’s proprietary non-diffractive X-WAVE™ technology, which stretches and shifts light without splitting it. 1 Vivity delivers monofocal-quality distance (far) with excellent intermediate (at arm’s length) and functional near vision (up close). *2 The lens expands Alcon’s growing portfolio of presbyopiaALCON
Convert K-readings to initial recommendation for our soft lensproducts. Content:
ALCON - FINANCIALS - ANNUAL REPORTS Alcon is incorporated outside the U.S. and qualifies as a foreign private issuer, or FPI. As long as we qualify as an FPI, we will be exempt from certain provisions of the Securities Exchange Act of 1934 that are applicable to U.S. domestic public companies, including: regulations governing the solicitation of proxies; consents or authorizations in respect of registered securities ALCON ANNOUNCES ACQUISITION OF POWERVISION, INC. Fort Worth, Texas, March 18, 2019 – Alcon, the global leader in eye care and a division of Novartis, announced today that it has acquired PowerVision, Inc., a privately-held, US-based medical device development company focused on creating fluid-based intraocular lens implants. The acquisition furthers Alcon’s commitment to bring this innovative, accommodating lens to cataract patients ALCON - NEWS AND EVENTS - EVENTS & PRESENTATIONS To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will ALCON - ALCON FILES FINAL 20F To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address.HOME | AU.ALCON.COM
We aspire to lead the world in innovating life-changing vision and eye care products because when people see brilliantly, they livebrilliantly
ALCON OFFICIAL SITE: DEVELOPING INNOVATIVE EYE CAREINNOVATIONCONTACT USCAREER SEARCHABOUT USINVESTOR RELATIONSMEDIA RELEASES At Alcon, we are proudly committed to creating a work culture that welcomes and celebrates diversity and inclusion. That’s why we are thrilled Alcon has earned a 95 percent rating on the Human Rights Campaign’s 2021 Corporate Equality Index.. Now in its 19th year, the Human Rights Campaign’s annual survey examines corporate policies and practices related to workplace equality for lesbian ALCON RESEARCH INSTITUTE Alcon Research Institute funds a “virtual institute” that seeks outstanding contributors to ophthalmic research throughout the world and honors them both in a symposium that elite members of the eye research community attend, as well as monetarily through researchgrants.
THIRD ANNUAL ALCON RETINA FELLOWS INSTITUTE GOES VIRTUAL Alcon, the global leader in eye care dedicated to helping people see brilliantly, will host the third annual Alcon Retina Fellows Institute – a unique educational experience which gathers 40 first-year Retina fellows for surgical training and mentorship from many leading ophthalmologists in the field across the United States. The Institute is convening virtually this year from November 19-21 ALCON ANNOUNCES LAUNCH OF ACRYSOF IQ VIVITY, THE FIRST AND Vivity is a first-of-its-kind, non-diffractive extended depth of focus IOL with Alcon’s proprietary non-diffractive X-WAVE™ technology, which stretches and shifts light without splitting it. 1 Vivity delivers monofocal-quality distance (far) with excellent intermediate (at arm’s length) and functional near vision (up close). *2 The lens expands Alcon’s growing portfolio of presbyopiaALCON
Convert K-readings to initial recommendation for our soft lensproducts. Content:
ALCON - FINANCIALS - ANNUAL REPORTS Alcon is incorporated outside the U.S. and qualifies as a foreign private issuer, or FPI. As long as we qualify as an FPI, we will be exempt from certain provisions of the Securities Exchange Act of 1934 that are applicable to U.S. domestic public companies, including: regulations governing the solicitation of proxies; consents or authorizations in respect of registered securities ALCON ANNOUNCES ACQUISITION OF POWERVISION, INC. Fort Worth, Texas, March 18, 2019 – Alcon, the global leader in eye care and a division of Novartis, announced today that it has acquired PowerVision, Inc., a privately-held, US-based medical device development company focused on creating fluid-based intraocular lens implants. The acquisition furthers Alcon’s commitment to bring this innovative, accommodating lens to cataract patients ALCON - NEWS AND EVENTS - EVENTS & PRESENTATIONS To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will ALCON - ALCON FILES FINAL 20F To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address.HOME | AU.ALCON.COM
We aspire to lead the world in innovating life-changing vision and eye care products because when people see brilliantly, they livebrilliantly
ALCON TO SHOWCASE VISION CARE INNOVATION, INCLUDING .q4default .bwlistdecimal { list-style-type: decimal }.q4default .bwlistdisc { list-style-type: disc }.q4default .bwuline { text-decoration: underline } 18 abstracts accepted, underscoring Alcon’s commitment to vision, comfort and ocular surface health TOTAL30 designed with water gradient technology that has biomimetic properties that mimic the corneal surface and demonstrates NEW ALCON DATA ON CONTACT LENS, DRY EYE AND OCULAR HEALTH Alcon, the global leader in eye care, will present new data on several of its latest contact lens, dry eye and ocular health innovations during the Association for Research in Vision and Ophthalmology (ARVO) 2021 virtual meeting taking place May 1-7. Alcon boasts a robust scientific showing at the meeting with nine accepted abstracts on vision care innovations including theALCON: CAREERS
Alcon is an Equal Opportunity Employer and participates in E-Verify. Alcon takes pride in maintaining a diverse environment and our policies are not to discriminate in recruitment, hiring, training, promotion or other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, gender identity, marital or veteran status, disability, or any other ALCON RESEARCH INSTITUTE Alcon Research Institute funds a “virtual institute” that seeks outstanding contributors to ophthalmic research throughout the world and honors them both in a symposium that elite members of the eye research community attend, as well as monetarily through researchgrants.
RESPONSIBLE BUSINESS PRACTICE We have a strong commitment to the diversity of our supplier base. To help us achieve our goals, we request that our majority suppliers actively participate in our Supplier Diversity initiative by seeking tier-two relationships with minorities, women, small businesses, veteran, disadvantaged veteran businesses, HubZone certified businesses and small disadvantaged businesses (SDB). ALCON ANNOUNCES LAUNCH OF ACRYSOF IQ VIVITY, THE FIRST AND Vivity is a first-of-its-kind, non-diffractive extended depth of focus IOL with Alcon’s proprietary non-diffractive X-WAVE™ technology, which stretches and shifts light without splitting it. 1 Vivity delivers monofocal-quality distance (far) with excellent intermediate (at arm’s length) and functional near vision (up close). *2 The lens expands Alcon’s growing portfolio of presbyopia ALCON FEATURES NEW TECHNOLOGY UPGRADES FOR THE ORA SYSTEM San Diego, California, April 14, 2015 – Alcon, the global leader in eye care, will introduce enhancements to both the ORA System ® and the VERION™ Image Guided System, providing improved capabilities and efficiency during both preoperative planning and intraoperative guidance during the cataract surgery procedure. The new VerifEye+™ Technology and VERION 2.6 software update will be ALCON - 2021 ANNUAL GENERAL MEETING To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. ALCON COMPREHENSIVE INTEGRITY AND COMPLIANCE … Title: Microsoft Word - Alcon.Comprehensive.Integrity.Compliance.Program.Description.Apr2019 Author: STONEST2 Created Date: 4/3/2019 5:28:22 PM CONTACT US | AU.ALCON.COM Australia. Alcon Laboratories (Australia) Pty Ltd ABN 88 000 740 830 Suite 1, Level 7, 15 Talavera Rd, Macquarie Park NSW 2113 General enquiries: 1800 224 153 For information about Alcon products or medical data, contact Medical Information on 1800 224 153 or Customer service: 1800 224 153 To report an adverse event or if you have a product complaint, you can contact us on ALCON OFFICIAL SITE: DEVELOPING INNOVATIVE EYE CAREINNOVATIONCONTACT USCAREER SEARCHABOUT USINVESTOR RELATIONSMEDIA RELEASES At Alcon, we are proudly committed to creating a work culture that welcomes and celebrates diversity and inclusion. That’s why we are thrilled Alcon has earned a 95 percent rating on the Human Rights Campaign’s 2021 Corporate Equality Index. Now in its 19th year, the Human Rights Campaign’s annual survey examines corporate policiesand
NEW ALCON DATA ON CONTACT LENS, DRY EYE AND OCULAR HEALTH Alcon, the global leader in eye care, will present new data on several of its latest contact lens, dry eye and ocular health innovations during the Association for Research in Vision and Ophthalmology (ARVO) 2021 virtual meeting taking place May 1-7. Alcon boasts a robust scientific showing at the meeting with nine accepted abstracts on vision care innovations including the ALCON - NEWS AND EVENTS - EVENTS & PRESENTATIONS Alcon’s Fourth Quarter and Full Year 2020 Earnings Conference Call. Webcast (opens in new window) Earnings Release (opens in new window) Form 20-F (opens in new window) Regulatory Filing (opens in new window) Presentation (opens in new window) 01/12/2021 02:00 PM ET. 39th Annual JP Morgan Healthcare Conference. Webcast (opens in newwindow)
THIRD ANNUAL ALCON RETINA FELLOWS INSTITUTE GOES VIRTUAL Alcon, the global leader in eye care dedicated to helping people see brilliantly, will host the third annual Alcon Retina Fellows Institute – a unique educational experience which gathers 40 first-year Retina fellows for surgical training and mentorship from many leading ophthalmologists in the field across the United States. The Institute is convening virtually this year from November 19-21 ALCON ANNOUNCES LAUNCH OF ACRYSOF IQ VIVITY, THE FIRST AND Vivity is a first-of-its-kind, non-diffractive extended depth of focus IOL with Alcon’s proprietary non-diffractive X-WAVE™ technology, which stretches and shifts light without splitting it. 1 Vivity delivers monofocal-quality distance (far) with excellent intermediate (at arm’s length) and functional near vision (up close). *2 The lens expands Alcon’s growing portfolio of presbyopiaALCON
Convert K-readings to initial recommendation for our soft lensproducts. Content:
ALCON - FINANCIALS - ANNUAL REPORTS Alcon is incorporated outside the U.S. and qualifies as a foreign private issuer, or FPI. As long as we qualify as an FPI, we will be exempt from certain provisions of the Securities Exchange Act of 1934 that are applicable to U.S. domestic public companies, including: regulations governing the solicitation of proxies; consents or authorizations in respect of registered securities ALCON ANNOUNCES ACQUISITION OF POWERVISION, INC. Fort Worth, Texas, March 18, 2019 – Alcon, the global leader in eye care and a division of Novartis, announced today that it has acquired PowerVision, Inc., a privately-held, US-based medical device development company focused on creating fluid-based intraocular lens implants. The acquisition furthers Alcon’s commitment to bring this innovative, accommodating lens to cataract patients ALCON - ALCON FILES FINAL 20F To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address.HOME | AU.ALCON.COM
See Brilliantly. We aspire to lead the world in innovating life-changing vision and eye care products because when people see brilliantly, they live brilliantly. lightshow. About Alcon. Careers. Corporate Responsibility. Please wait for your event to start. The event has now ended. 0:00 | 1:27 LIVE. ALCON OFFICIAL SITE: DEVELOPING INNOVATIVE EYE CAREINNOVATIONCONTACT USCAREER SEARCHABOUT USINVESTOR RELATIONSMEDIA RELEASES At Alcon, we are proudly committed to creating a work culture that welcomes and celebrates diversity and inclusion. That’s why we are thrilled Alcon has earned a 95 percent rating on the Human Rights Campaign’s 2021 Corporate Equality Index. Now in its 19th year, the Human Rights Campaign’s annual survey examines corporate policiesand
NEW ALCON DATA ON CONTACT LENS, DRY EYE AND OCULAR HEALTH Alcon, the global leader in eye care, will present new data on several of its latest contact lens, dry eye and ocular health innovations during the Association for Research in Vision and Ophthalmology (ARVO) 2021 virtual meeting taking place May 1-7. Alcon boasts a robust scientific showing at the meeting with nine accepted abstracts on vision care innovations including the ALCON - NEWS AND EVENTS - EVENTS & PRESENTATIONS Alcon’s Fourth Quarter and Full Year 2020 Earnings Conference Call. Webcast (opens in new window) Earnings Release (opens in new window) Form 20-F (opens in new window) Regulatory Filing (opens in new window) Presentation (opens in new window) 01/12/2021 02:00 PM ET. 39th Annual JP Morgan Healthcare Conference. Webcast (opens in newwindow)
THIRD ANNUAL ALCON RETINA FELLOWS INSTITUTE GOES VIRTUAL Alcon, the global leader in eye care dedicated to helping people see brilliantly, will host the third annual Alcon Retina Fellows Institute – a unique educational experience which gathers 40 first-year Retina fellows for surgical training and mentorship from many leading ophthalmologists in the field across the United States. The Institute is convening virtually this year from November 19-21 ALCON ANNOUNCES LAUNCH OF ACRYSOF IQ VIVITY, THE FIRST AND Vivity is a first-of-its-kind, non-diffractive extended depth of focus IOL with Alcon’s proprietary non-diffractive X-WAVE™ technology, which stretches and shifts light without splitting it. 1 Vivity delivers monofocal-quality distance (far) with excellent intermediate (at arm’s length) and functional near vision (up close). *2 The lens expands Alcon’s growing portfolio of presbyopiaALCON
Convert K-readings to initial recommendation for our soft lensproducts. Content:
ALCON - FINANCIALS - ANNUAL REPORTS Alcon is incorporated outside the U.S. and qualifies as a foreign private issuer, or FPI. As long as we qualify as an FPI, we will be exempt from certain provisions of the Securities Exchange Act of 1934 that are applicable to U.S. domestic public companies, including: regulations governing the solicitation of proxies; consents or authorizations in respect of registered securities ALCON ANNOUNCES ACQUISITION OF POWERVISION, INC. Fort Worth, Texas, March 18, 2019 – Alcon, the global leader in eye care and a division of Novartis, announced today that it has acquired PowerVision, Inc., a privately-held, US-based medical device development company focused on creating fluid-based intraocular lens implants. The acquisition furthers Alcon’s commitment to bring this innovative, accommodating lens to cataract patients ALCON - ALCON FILES FINAL 20F To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address.HOME | AU.ALCON.COM
See Brilliantly. We aspire to lead the world in innovating life-changing vision and eye care products because when people see brilliantly, they live brilliantly. lightshow. About Alcon. Careers. Corporate Responsibility. Please wait for your event to start. The event has now ended. 0:00 | 1:27 LIVE. ALCON TO SHOWCASE VISION CARE INNOVATION, INCLUDING .q4default .bwlistdecimal { list-style-type: decimal }.q4default .bwlistdisc { list-style-type: disc }.q4default .bwuline { text-decoration: underline } 18 abstracts accepted, underscoring Alcon’s commitment to vision, comfort and ocular surface health TOTAL30 designed with water gradient technology that has biomimetic properties that mimic the corneal surface and demonstrates NEW ALCON DATA ON CONTACT LENS, DRY EYE AND OCULAR HEALTH Alcon, the global leader in eye care, will present new data on several of its latest contact lens, dry eye and ocular health innovations during the Association for Research in Vision and Ophthalmology (ARVO) 2021 virtual meeting taking place May 1-7. Alcon boasts a robust scientific showing at the meeting with nine accepted abstracts on vision care innovations including theALCON: CAREERS
Alcon is an Equal Opportunity Employer and participates in E-Verify. Alcon takes pride in maintaining a diverse environment and our policies are not to discriminate in recruitment, hiring, training, promotion or other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, gender identity, marital or veteran status, disability, or any other RESPONSIBLE BUSINESS PRACTICE The Alcon Ethics Helpline is an independently managed, confidential online and telephone service available 24 hours a day, 7 days a week, in multiple languages. Concerns may be reported anonymously through the Helpline, where allowed under local law. For details about how to report, visit Alcon.Ethicspoint.com. ALCON ANNOUNCES LAUNCH OF ACRYSOF IQ VIVITY, THE FIRST AND Vivity is a first-of-its-kind, non-diffractive extended depth of focus IOL with Alcon’s proprietary non-diffractive X-WAVE™ technology, which stretches and shifts light without splitting it. 1 Vivity delivers monofocal-quality distance (far) with excellent intermediate (at arm’s length) and functional near vision (up close). *2 The lens expands Alcon’s growing portfolio of presbyopia ALCON - 2021 ANNUAL GENERAL MEETING 2021 Annual General Meeting. April 28, 2021. Voting Results. (opens in new window) PDF 85 KB. AGM Minutes. (opens in new window) PDF 85 KB. ALCON FEATURES NEW TECHNOLOGY UPGRADES FOR THE ORA SYSTEM San Diego, California, April 14, 2015 – Alcon, the global leader in eye care, will introduce enhancements to both the ORA System ® and the VERION™ Image Guided System, providing improved capabilities and efficiency during both preoperative planning and intraoperative guidance during the cataract surgery procedure. The new VerifEye+™ Technology and VERION 2.6 software update will be ALCON COMPREHENSIVE INTEGRITY AND COMPLIANCE PROGRAM Title: Microsoft Word - Alcon.Comprehensive.Integrity.Compliance.Program.Description.Apr2019 Author: STONEST2 Created Date: 4/3/2019 5:28:22 PM HOME | ALCON.COMTRANSLATE THIS PAGE Wie optimaal ziet, leeft optimaal. Daarom streeft Alcon er elke dag naar om wereldleider te zijn in het bieden van optimale ooggezondheid en innoverende oogzorgproducten. lightshow. Over Alcon. Carrière bijAlcon.
CONTACT US | AU.ALCON.COM General enquiries: 1800 224 153. For information about Alcon products or medical data, contact Medical Information on 1800 224 153 or australia.auff-medical_information@alcon.com. Customer service: 1800 224 153. To report an adverse event or if you have a product complaint, you can contact us on 1800 224 153 or australia.auff-complaints@alcon.com. ALCON OFFICIAL SITE: DEVELOPING INNOVATIVE EYE CAREINNOVATIONCONTACT USCAREER SEARCHABOUT USINVESTOR RELATIONSMEDIA RELEASES At Alcon, we are proudly committed to creating a work culture that welcomes and celebrates diversity and inclusion. That’s why we are thrilled Alcon has earned a 95 percent rating on the Human Rights Campaign’s 2021 Corporate Equality Index.. Now in its 19th year, the Human Rights Campaign’s annual survey examines corporate policies and practices related to workplace equality for lesbianALCON: CAREERS
Alcon is an Equal Opportunity Employer and participates in E-Verify. Alcon takes pride in maintaining a diverse environment and our policies are not to discriminate in recruitment, hiring, training, promotion or other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, gender identity, marital or veteran status, disability, or any other CORPORATE SOCIAL RESPONSIBILITY Corporate Responsibility Report. Alcon has been actively engaged in environmental, social and governance (ESG) initiatives during our 70+ years in ophthalmology and optometry. In publishing our first Corporate Responsibility Report as an independent, standalone company, we are sharing our perspective on corporate citizenship anddemonstrating
RESPONSIBLE BUSINESS PRACTICE The Alcon Ethics Helpline is an independently managed, confidential online and telephone service available 24 hours a day, 7 days a week, in multiple languages. Concerns may be reported anonymously through the Helpline, where allowed under local law. For details about how to report, visit Alcon.Ethicspoint.com.ALCON
Convert K-readings to initial recommendation for our soft lensproducts. Content:
ALCON - NEWS AND EVENTS - EVENTS & PRESENTATIONS Alcon’s Fourth Quarter and Full Year 2020 Earnings Conference Call. Webcast (opens in new window) Earnings Release (opens in new window) Form 20-F (opens in new window) Regulatory Filing (opens in new window) Presentation (opens in new window) 01/12/2021 02:00 PM ET. 39th Annual JP Morgan Healthcare Conference. Webcast (opens in newwindow)
ALCON - INVESTOR RELATIONS Alcon is the world leader in eye care, dedicated to helping people see brilliantly. With our 70-plus-year heritage, we are the largest eye care device company in the world – with complementary businesses in Surgical and Vision Care. ALCON ANNOUNCES LAUNCH OF ACRYSOF IQ VIVITY, THE FIRST AND Vivity is a first-of-its-kind, non-diffractive extended depth of focus IOL with Alcon’s proprietary non-diffractive X-WAVE™ technology, which stretches and shifts light without splitting it. 1 Vivity delivers monofocal-quality distance (far) with excellent intermediate (at arm’s length) and functional near vision (up close). *2 The lens expands Alcon’s growing portfolio of presbyopia ALCON - FINANCIALS - ANNUAL REPORTS Alcon is incorporated outside the U.S. and qualifies as a foreign private issuer, or FPI. As long as we qualify as an FPI, we will be exempt from certain provisions of the Securities Exchange Act of 1934 that are applicable to U.S. domestic public companies, including: regulations governing the solicitation of proxies; consents or authorizations in respect of registered securities ALCON - ALCON FILES FINAL 20F To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. ALCON OFFICIAL SITE: DEVELOPING INNOVATIVE EYE CAREINNOVATIONCONTACT USCAREER SEARCHABOUT USINVESTOR RELATIONSMEDIA RELEASES At Alcon, we are proudly committed to creating a work culture that welcomes and celebrates diversity and inclusion. That’s why we are thrilled Alcon has earned a 95 percent rating on the Human Rights Campaign’s 2021 Corporate Equality Index.. Now in its 19th year, the Human Rights Campaign’s annual survey examines corporate policies and practices related to workplace equality for lesbianALCON: CAREERS
Alcon is an Equal Opportunity Employer and participates in E-Verify. Alcon takes pride in maintaining a diverse environment and our policies are not to discriminate in recruitment, hiring, training, promotion or other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, gender identity, marital or veteran status, disability, or any other CORPORATE SOCIAL RESPONSIBILITY Corporate Responsibility Report. Alcon has been actively engaged in environmental, social and governance (ESG) initiatives during our 70+ years in ophthalmology and optometry. In publishing our first Corporate Responsibility Report as an independent, standalone company, we are sharing our perspective on corporate citizenship anddemonstrating
RESPONSIBLE BUSINESS PRACTICE The Alcon Ethics Helpline is an independently managed, confidential online and telephone service available 24 hours a day, 7 days a week, in multiple languages. Concerns may be reported anonymously through the Helpline, where allowed under local law. For details about how to report, visit Alcon.Ethicspoint.com.ALCON
Convert K-readings to initial recommendation for our soft lensproducts. Content:
ALCON - NEWS AND EVENTS - EVENTS & PRESENTATIONS Alcon’s Fourth Quarter and Full Year 2020 Earnings Conference Call. Webcast (opens in new window) Earnings Release (opens in new window) Form 20-F (opens in new window) Regulatory Filing (opens in new window) Presentation (opens in new window) 01/12/2021 02:00 PM ET. 39th Annual JP Morgan Healthcare Conference. Webcast (opens in newwindow)
ALCON - INVESTOR RELATIONS Alcon is the world leader in eye care, dedicated to helping people see brilliantly. With our 70-plus-year heritage, we are the largest eye care device company in the world – with complementary businesses in Surgical and Vision Care. ALCON ANNOUNCES LAUNCH OF ACRYSOF IQ VIVITY, THE FIRST AND Vivity is a first-of-its-kind, non-diffractive extended depth of focus IOL with Alcon’s proprietary non-diffractive X-WAVE™ technology, which stretches and shifts light without splitting it. 1 Vivity delivers monofocal-quality distance (far) with excellent intermediate (at arm’s length) and functional near vision (up close). *2 The lens expands Alcon’s growing portfolio of presbyopia ALCON - FINANCIALS - ANNUAL REPORTS Alcon is incorporated outside the U.S. and qualifies as a foreign private issuer, or FPI. As long as we qualify as an FPI, we will be exempt from certain provisions of the Securities Exchange Act of 1934 that are applicable to U.S. domestic public companies, including: regulations governing the solicitation of proxies; consents or authorizations in respect of registered securities ALCON - ALCON FILES FINAL 20F To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. ALCON TO SHOWCASE VISION CARE INNOVATION, INCLUDING .q4default .bwlistdecimal { list-style-type: decimal }.q4default .bwlistdisc { list-style-type: disc }.q4default .bwuline { text-decoration: underline } 18 abstracts accepted, underscoring Alcon’s commitment to vision, comfort and ocular surface health TOTAL30 designed with water gradient technology that has biomimetic properties that mimic the corneal surface and demonstrates TECHNICAL PRODUCT INFORMATION ACRYSERT® Delivery System MODEL SN6CWS Product Information ACRYSOF® Aspheric UV Absorbing ReSTOR +2.5 D Toric IOL ALCON RESEARCH INSTITUTE Alcon Research Institute. In 1981, Alcon set out to help support research in eye health and to expand the frontiers of vision sciences globally – from this concept Alcon Research Institute (ARI) was born. Since then, the ARI has had a significant impact on the study of ocular diseases and has become a bridge to building partnerships with ALCON ANNOUNCES LAUNCH OF ACRYSOF IQ VIVITY, THE FIRST AND Vivity is a first-of-its-kind, non-diffractive extended depth of focus IOL with Alcon’s proprietary non-diffractive X-WAVE™ technology, which stretches and shifts light without splitting it. 1 Vivity delivers monofocal-quality distance (far) with excellent intermediate (at arm’s length) and functional near vision (up close). *2 The lens expands Alcon’s growing portfolio of presbyopia ALCON - NEWS AND EVENTS - EVENTS & PRESENTATIONS Alcon’s Fourth Quarter and Full Year 2020 Earnings Conference Call. Webcast (opens in new window) Earnings Release (opens in new window) Form 20-F (opens in new window) Regulatory Filing (opens in new window) Presentation (opens in new window) 01/12/2021 02:00 PM ET. 39th Annual JP Morgan Healthcare Conference. Webcast (opens in newwindow)
ALCON - INVESTOR RELATIONS Alcon is the world leader in eye care, dedicated to helping people see brilliantly. With our 70-plus-year heritage, we are the largest eye care device company in the world – with complementary businesses in Surgical and Vision Care. JOB SEARCH | ALCON.COM Privacy Policy; Cookie Notice; Terms of Use; Investors; Site Map; California Resident? Do Not Sell My Personal Information ALCON FEATURES NEW TECHNOLOGY UPGRADES FOR THE ORA SYSTEM San Diego, California, April 14, 2015 – Alcon, the global leader in eye care, will introduce enhancements to both the ORA System ® and the VERION™ Image Guided System, providing improved capabilities and efficiency during both preoperative planning and intraoperative guidance during the cataract surgery procedure. The new VerifEye+™ Technology and VERION 2.6 software update will be ALCON - FINANCIALS - QUARTERLY RESULTS Alcon is incorporated outside the U.S. and qualifies as a foreign private issuer, or FPI. As long as we qualify as an FPI, we will be exempt from certain provisions of the Securities Exchange Act of 1934 that are applicable to U.S. domestic public companies, including: regulations governing the solicitation of proxies; consents or authorizations in respect of registered securitiesHOME | AU.ALCON.COM
See Brilliantly. We aspire to lead the world in innovating life-changing vision and eye care products because when people see brilliantly, they live brilliantly. lightshow. About Alcon. Careers. Corporate Responsibility. Please wait for your event to start. The event has now ended. 0:00 | 1:27 LIVE. ALCON OFFICIAL SITE: DEVELOPING INNOVATIVE EYE CAREINNOVATIONCONTACT USCAREER SEARCHABOUT USINVESTOR RELATIONSMEDIA RELEASES At Alcon, we are proudly committed to creating a work culture that welcomes and celebrates diversity and inclusion. That’s why we are thrilled Alcon has earned a 95 percent rating on the Human Rights Campaign’s 2021 Corporate Equality Index.. Now in its 19th year, the Human Rights Campaign’s annual survey examines corporate policies and practices related to workplace equality for lesbianALCON: CAREERS
Alcon is an Equal Opportunity Employer and participates in E-Verify. Alcon takes pride in maintaining a diverse environment and our policies are not to discriminate in recruitment, hiring, training, promotion or other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, gender identity, marital or veteran status, disability, or any other CORPORATE SOCIAL RESPONSIBILITY Alcon’s Corporate Giving efforts, including the Alcon Foundation and Alcon Cares, help people around the world by increasing access to quality eye care, driving eye care provider training and skills-transfer and strengthening the communities in which we live andwork.
RESPONSIBLE BUSINESS PRACTICE We are committed to demonstrating integrity in everything we do. What we do at Alcon is critical to help people see better; how we conduct our business in the workplace, in the marketplace, and in society determines our success as a business. We believe in conducting our business fairly and ethically and in a manner consistent with all applicable legal and industry code requirements.ALCON
Convert K-readings to initial recommendation for our soft lensproducts. Content:
ALCON - INVESTOR RELATIONS Alcon is the world leader in eye care, dedicated to helping people see brilliantly. With our 70-plus-year heritage, we are the largest eye care device company in the world – with complementary businesses in Surgical and Vision Care. ALCON ANNOUNCES LAUNCH OF ACRYSOF IQ VIVITY, THE FIRST AND Vivity is a first-of-its-kind, non-diffractive extended depth of focus IOL with Alcon’s proprietary non-diffractive X-WAVE™ technology, which stretches and shifts light without splitting it. 1 Vivity delivers monofocal-quality distance (far) with excellent intermediate (at arm’s length) and functional near vision (up close). *2 The lens expands Alcon’s growing portfolio of presbyopia ALCON - FINANCIALS - ANNUAL REPORTS Alcon is incorporated outside the U.S. and qualifies as a foreign private issuer, or FPI. As long as we qualify as an FPI, we will be exempt from certain provisions of the Securities Exchange Act of 1934 that are applicable to U.S. domestic public companies, including: regulations governing the solicitation of proxies; consents or authorizations in respect of registered securities ALCON ANNOUNCES ACQUISITION OF POWERVISION, INC. Fort Worth, Texas, March 18, 2019 – Alcon, the global leader in eye care and a division of Novartis, announced today that it has acquired PowerVision, Inc., a privately-held, US-based medical device development company focused on creating fluid-based intraocular lens implants. The acquisition furthers Alcon’s commitment to bring this innovative, accommodating lens to cataract patients ALCON - ALCON FILES FINAL 20F To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. ALCON OFFICIAL SITE: DEVELOPING INNOVATIVE EYE CAREINNOVATIONCONTACT USCAREER SEARCHABOUT USINVESTOR RELATIONSMEDIA RELEASES At Alcon, we are proudly committed to creating a work culture that welcomes and celebrates diversity and inclusion. That’s why we are thrilled Alcon has earned a 95 percent rating on the Human Rights Campaign’s 2021 Corporate Equality Index.. Now in its 19th year, the Human Rights Campaign’s annual survey examines corporate policies and practices related to workplace equality for lesbianALCON: CAREERS
Alcon is an Equal Opportunity Employer and participates in E-Verify. Alcon takes pride in maintaining a diverse environment and our policies are not to discriminate in recruitment, hiring, training, promotion or other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, gender identity, marital or veteran status, disability, or any other CORPORATE SOCIAL RESPONSIBILITY Alcon’s Corporate Giving efforts, including the Alcon Foundation and Alcon Cares, help people around the world by increasing access to quality eye care, driving eye care provider training and skills-transfer and strengthening the communities in which we live andwork.
RESPONSIBLE BUSINESS PRACTICE We are committed to demonstrating integrity in everything we do. What we do at Alcon is critical to help people see better; how we conduct our business in the workplace, in the marketplace, and in society determines our success as a business. We believe in conducting our business fairly and ethically and in a manner consistent with all applicable legal and industry code requirements.ALCON
Convert K-readings to initial recommendation for our soft lensproducts. Content:
ALCON - INVESTOR RELATIONS Alcon is the world leader in eye care, dedicated to helping people see brilliantly. With our 70-plus-year heritage, we are the largest eye care device company in the world – with complementary businesses in Surgical and Vision Care. ALCON ANNOUNCES LAUNCH OF ACRYSOF IQ VIVITY, THE FIRST AND Vivity is a first-of-its-kind, non-diffractive extended depth of focus IOL with Alcon’s proprietary non-diffractive X-WAVE™ technology, which stretches and shifts light without splitting it. 1 Vivity delivers monofocal-quality distance (far) with excellent intermediate (at arm’s length) and functional near vision (up close). *2 The lens expands Alcon’s growing portfolio of presbyopia ALCON - FINANCIALS - ANNUAL REPORTS Alcon is incorporated outside the U.S. and qualifies as a foreign private issuer, or FPI. As long as we qualify as an FPI, we will be exempt from certain provisions of the Securities Exchange Act of 1934 that are applicable to U.S. domestic public companies, including: regulations governing the solicitation of proxies; consents or authorizations in respect of registered securities ALCON ANNOUNCES ACQUISITION OF POWERVISION, INC. Fort Worth, Texas, March 18, 2019 – Alcon, the global leader in eye care and a division of Novartis, announced today that it has acquired PowerVision, Inc., a privately-held, US-based medical device development company focused on creating fluid-based intraocular lens implants. The acquisition furthers Alcon’s commitment to bring this innovative, accommodating lens to cataract patients ALCON - ALCON FILES FINAL 20F To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. ALCON TO SHOWCASE VISION CARE INNOVATION, INCLUDING .q4default .bwlistdecimal { list-style-type: decimal }.q4default .bwlistdisc { list-style-type: disc }.q4default .bwuline { text-decoration: underline } 18 abstracts accepted, underscoring Alcon’s commitment to vision, comfort and ocular surface health TOTAL30 designed with water gradient technology that has biomimetic properties that mimic the corneal surface and demonstrates TECHNICAL PRODUCT INFORMATION ACRYSERT® Delivery System MODEL SN6CWS Product Information ACRYSOF® Aspheric UV Absorbing ReSTOR +2.5 D Toric IOL NEW ALCON DATA ON CONTACT LENS, DRY EYE AND OCULAR HEALTH Alcon, the global leader in eye care, will present new data on several of its latest contact lens, dry eye and ocular health innovations during the Association for Research in Vision and Ophthalmology (ARVO) 2021 virtual meeting taking place May 1-7. Alcon boasts a robust scientific showing at the meeting with nine accepted abstracts on vision care innovations including the ALCON RESEARCH INSTITUTE Alcon Research Institute funds a “virtual institute” that seeks outstanding contributors to ophthalmic research throughout the world and honors them both in a symposium that elite members of the eye research community attend, as well as monetarily through researchgrants.
ALCON ANNOUNCES LAUNCH OF ACRYSOF IQ VIVITY, THE FIRST AND Vivity is a first-of-its-kind, non-diffractive extended depth of focus IOL with Alcon’s proprietary non-diffractive X-WAVE™ technology, which stretches and shifts light without splitting it. 1 Vivity delivers monofocal-quality distance (far) with excellent intermediate (at arm’s length) and functional near vision (up close). *2 The lens expands Alcon’s growing portfolio of presbyopia JOB SEARCH | ALCON.COM Privacy Policy; Cookie Notice; Terms of Use; Investors; Site Map; California Resident? Do Not Sell My Personal Information ALCON - INVESTOR RELATIONS Alcon is the world leader in eye care, dedicated to helping people see brilliantly. With our 70-plus-year heritage, we are the largest eye care device company in the world – with complementary businesses in Surgical and Vision Care. ALCON FEATURES NEW TECHNOLOGY UPGRADES FOR THE ORA SYSTEM San Diego, California, April 14, 2015 – Alcon, the global leader in eye care, will introduce enhancements to both the ORA System ® and the VERION™ Image Guided System, providing improved capabilities and efficiency during both preoperative planning and intraoperative guidance during the cataract surgery procedure. The new VerifEye+™ Technology and VERION 2.6 software update will be ALCON - NEWS AND EVENTS - EVENTS & PRESENTATIONS To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you willHOME | AU.ALCON.COM
We aspire to lead the world in innovating life-changing vision and eye care products because when people see brilliantly, they livebrilliantly
Go to main content.
Alcon Company
Menu
Close
Location MyAlcon
Search
* Patients
*
Eye Care Professionals * Eye Care Professionals * U.S. COVID-19 Resource Center*
About Alcon
* About Alcon
* Our History
* Our Business Focus * Investor Relations* Newsroom
* Corporate Social Responsibility * Responsible Business Practices* Leadership
* Careers
*
Innovation
* Innovation
* Sight Matters
* Range of Products
* A Pipeline for the Future * Alcon Research Institute* Partnerships
* Newsroom
Your browser does not support the video tag. We aspire to lead the world in innovating life-changing vision and eye care products because when people see brilliantly, they livebrilliantly
*
Sight
*
Innovation
*
Eye Health for Everyone Alcon Recognized on the Corporate Equality Index for the Second Yearin a Row
At Alcon, we are proudly committed to creating a work culture that welcomes and celebrates diversity and inclusion. Show moreShow less
At Alcon, we are proudly committed to creating a work culture that welcomes and celebrates diversity and inclusion. That’s why we are thrilled Alcon has earned a 95 percent rating on the Human Rights Campaign’s 2021 Corporate Equality Index.
Now in its 19th year, the Human Rights Campaign’s annual survey examines corporate policies and practices related to workplace equality for lesbian, gay, bisexual, transgender, and queer (LGBTQ+) individuals and their families. The survey results are an important way to gauge the inclusiveness that exists within a company. Alcon’s latest results are a testament to our strong and continued commitment to evolving our culture to be more diverse and inclusive. Since our inaugural listing in 2020 with a score of 90%, our LGBTQ+ employee resource group, Open Professional Employee Network (OPEN), has worked closely with our HR and Benefits team, Chief Diversity & Inclusion Officer, as well as our Executive Leadership Team, to examine our policies and drive positive change within Alcon. The year-over-year improvement in our score demonstrates great momentum in driving equality in our policies. While we celebrate our journey so far, we continue to look up and aim for a perfect score of 100, which we believe is within our reach. As a company, we are committed to put in the work to continue creating awareness, educating, and challenging norms to be inclusive in every possible way. Only when our associates can be their true authentic selves, can we unlock our full potential to realize our purpose of helping people around the world see brilliantly. GET A CAREER AT ALCONCAREERS AT ALCON
Contact us
* YouTube
See Brilliantly
* Privacy Policy
* Cookie Notice
* Terms of Use
* Investors
* Site Map
* California Resident? Do Not Sell My Personal InformationOUR USE OF COOKIES
We use cookies that are strictly necessary to make our site work. We would also like to set optional cookies for the purposes of improving site content, personalizing content, tailoring advertising to your interests, and measuring site usage. By clicking "Accept and Continue" you are agreeing to the use of these cookies. Alternately, you can customize the cookies by clicking on "Manage Cookie Settings". For more information on our use of cookies, please visit our Cookie Noticepage.
Accept & Continue
Accept & Continue
Manage Cookie SettingsDetails
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0